Benecchi Christopher 4
4 · Sage Therapeutics, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Benecchi Christopher
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2025-02-13$7.18/sh−822$5,902→ 43,915 total
Footnotes (1)
- [F1]On February 13, 2025, the reporting person vested 3,375 shares of time-based restricted stock units (RSUs) granted on February 13, 2024 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.